Caffeine is the most widely used stimulant in the world. The stimulant effects of caffeine are mediated through its antagonistic properties on neuronal adenosine receptors. In addition, caffeine blocks neurovascular adenosine receptors and decreases cerebral perfusion. Although the effects of caffeine on blood oxygenation level-dependent (BOLD) functional magnetic resonance imaging measures are extremely important, there are few studies addressing this issue in the literature. Because chronic caffeine use causes an upregulation of adenosine receptors, the differential effects of caffeine in low and high users is of particular interest. The present study was designed to test the hypothesis that caffeine has differential effects on the BOLD signal in high and low caffeine users. We demonstrated that the BOLD signal change in visual cortex was significantly greater in high users than in low users in the presence of caffeine. In addition, the magnitude of the BOLD signal was significantly correlated with caffeine consumption. We propose that the outcome observed here was due to an upregulation of adenosine receptors in high users, resulting in differential contributions of the neural and vascular effects of adenosine in the two study populations. © 2002 Elsevier Science (USA)
INTRODUCTION
Caffeine is the most widely used neurostimulant in the world and is found in a variety of foods and beverages, including coffee, tea, soft drinks, and chocolate. Caffeine consumption has been estimated at 76 mg/ person per day worldwide, as high as 238 mg/person/ day in the United States, and more than 400 mg/ person/day in Sweden and Finland (Nehlig, 1999) . Caffeine is a nonselective antagonist of adenosine receptors (Ralevic and Burnstock, 1998) and acts not only as a neurostimulant but also as a vasoconstrictor. Recently it has been reported that caffeine enhances the blood oxygenation level-dependent (BOLD) signal in functional magnetic resonance (fMRI) studies (Mulderink et al., 2002; Parrish et al., 2001) . However, it is well known that chronic caffeine use causes an upregulation of adenosine receptors (Johansson et al., 1993; Ralevic and Burnstock, 1998) , and no study has evaluated the effects of caffeine on BOLD responses while controlling for dietary caffeine consumption.
The neurostimulant effects of caffeine are due to the antagonism of neural adenosine receptors. Adenosine has a general inhibitory effect on neural activity mediated by both A 1 and A 2A receptors (Dunwiddie and Masino, 2001) . However, neural A 1 receptors are widely distributed throughout the brain, whereas A 2A receptors are localized primarily in the striatum, nucleus accumbens, and olfactory tubercle (Dunwiddie and Masino, 2001; Moreau and Huber, 1999) . Therefore, adenosine-induced neural inhibition is thought to be primarily due to the activation of A 1 receptors (Dunwiddie and Masino, 2001; Haas and Selbach, 2000) . Adenosine-induced vasodilatation and subsequent increased cerebral perfusion is mediated primarily by A 2A on the neurovasculature (Coney and Marshall, 1998; Feoktistov and Biaggioni, 1997; Ngai et al., 2001; Shin et al., 2000) . Although each of these receptor subtypes can be upregulated following chronic caffeine consumption, it has been demonstrated that A 1 receptors are more prone to upregulation following chronic blockade than A 2A receptors (Johansson et al., 1993; Ralevic and Burnstock, 1998; Shi and Daly, 1999) . In addition, it has been suggested that the effect of caffeine on BOLD signal changes may be dependent on chronic caffeine usage and withdrawal due to the fact that chronic caffeine use results in an upregulation of adenosine receptors (Dager and Friedman, 2000; Johansson et al., 1993; Mulderink et al., 2002; Ralevic and Burnstock, 1998) . In fact, recent studies have demonstrated that chronic use and withdrawal modulate the stimulant effects of caffeine, associated electroencephalography changes, and resting cerebral perfusion Jones et al., 2000; Mathew et al., 1983; Mathew and Wilson, 1985; Swerdlow et al., 2000) .
However, no study has directly examined the effect of chronic caffeine use and/or withdrawal on stimulation-induced changes in the BOLD signal. In the cur-rent study we evaluated the effect of caffeine on fMRI measures in a population of high caffeine users (mean weekly intake was equivalent to 27 cups of coffee) and a population of low users (mean weekly intake was equivalent to 2 cups of coffee). The experiments were designed to test the hypothesis that caffeine has differential effects on the BOLD signal in high and low caffeine users during passive sensory stimulation. The blinded, placebo-controlled study design allowed for the evaluation of caffeine withdrawal and differentiation of the effects of caffeine on subjects with low or high caffeine consumption.
METHODS

Subjects and Study Design
Twenty healthy adult volunteers (16 men, 4 women, ages 24 -64 years), participated in the study under the following inclusion criteria: no history of migraines, stroke, hypertension, diabetes, or any neurological or vascular disease; no history of alcohol or drug abuse; and no use of tobacco products or oral contraceptives, both of which alter the plasma half-life of caffeine (Leonard et al., 1987) . Subjects' average daily caffeine intake was estimated from their responses to a dietary questionnaire using published data on the caffeine content of common beverages (Bunker and McWilliams, 1979) . Subjects were then categorized by their caffeine use as low (Ͻ120 mg/day, mean 41 mg/day, range 6 -118 mg/day, 10 subjects) or moderate to high (Ͼ300 mg/day, mean 648 mg/day, range 300 -1270 mg/day, 10 subjects). For simplicity, individuals that consumed Ͻ120 mg/day will be referred to hereafter as "low users" and subjects that consumed Ͼ300 mg/day will be referred to as "high users."
Each subject underwent two fMRI scans (passive visual and passive auditory stimulation) that were each repeated on two different days. Subjects were randomized to receive caffeine (250-mg capsule, equivalent to approximately 2 cups of coffee) on one day and placebo (250-mg lactose capsule) on the other day in a single blind, counterbalanced design. The caffeine and placebo capsules were made specifically for this study by the pharmacy department at our institution. All doses of caffeine or placebo were preceded by at least 30 h of caffeine abstinence, such that the placebo condition would reflect a state of withdrawal in the high caffeine users (Dager and Friedman, 2000) .
Subjects were instructed to maintain fixation on a gray cross in the center of a projection screen and to concentrate on the visual and auditory stimuli that were to be presented. The visual stimulus, a black (0.8 lu/m 2 ) and white (62 lu/m 2 ) checkerboard that encompassed 3°of visual space, was displayed in the center of a back-projection screen. The binaural auditory stimulus, a white noise burst with a 10-ms rise and fall time, was delivered through MR-compatible headphones (Resonance Technology Inc., Los Angeles, CA). A stimulus-timing program (E-Prime, Psychology Software Tools, Pittsburgh, PA) controlled all stimulus presentations. Each individual stimulus was 250 ms in duration presented at a rate of 2 Hz during a 30-s period. Each test period was bounded by 30-s rest periods. This "ON-OFF" epoch design resulted in three "ON" periods and four "OFF" periods for each scan. The order of presentation of the stimulation paradigms was randomized across subjects. To avoid false positive results due to stimulus correlated head motion, we excluded subjects with correlation coefficients greater than 0.5 (Field et al., 2000) . One low user was excluded from the final analyses based on this criterion. After receiving an explanation of the scanning procedure, subjects gave written informed consent. The Wake Forest University School of Medicine Institutional Review Board for Human Subjects approved this study.
fMRI Acquisition
All imaging experiments were performed on a 1.5-T GE echo-speed Horizon LX MR scanner with a birdcage headcoil (GE Medical Systems, Milwaukee, WI). Whole-brain activation was assessed by examining the BOLD changes in T2*-relaxation rate that accompany cortical activation (Ogawa et al., 1990 (Ogawa et al., , 1993 . Functional imaging was performed in the axial plane using multislice gradient-echo echo planar imaging with a field of view of 24 cm (frequency) ϫ 15 cm (phase) and an acquisition matrix of 64 ϫ 40 (28 slices, 5-mm thickness, no skip, TR, 2500, TE, 40). This sequence delivered an effective voxel resolution of 3.72 ϫ 3.75 ϫ 5 mm.
Anatomical Image Acquisition
High-resolution structural scans were obtained using a 3D spoiled gradient echo (3DSPGR) sequence with the following parameters: 256 ϫ 256; field of view, 24 cm; section thickness, 3 mm with no gap between sections; number of sections, 60; in-plane resolution, 0.94 mm. The T1-weighted images were normalized to a standard template in MNI coordinate space within SPM99. The anatomic images from all of the 19 subjects were then averaged to generate the mean image that is used in the figures.
Functional Image Analysis
Statistical parametric maps (SPMs) were generated using SPM99 (Friston et al., 1995 b,c) , from the Wellcome Department of Cognitive Neurology (London, UK) implemented in Matlab (The Mathworks Inc. Sherborn, MA) with an IDL (Research Systems Inc., Boulder, CO) interface. Prior to generating SPMs, data were motion corrected within SPM99 (Friston et al., 1995a) , normalized to Montreal Neurological Institute (MNI) space using image header information (Maldjian et al., 1997) in combination with the SPM99 normalization (Friston et al., 1995a) and resampled to 4 ϫ 4 ϫ 5 mm using sinc interpolation. The data sets were smoothed using an 8 ϫ 8 ϫ 10 mm full-width-halfmaximum Gaussian kernel. The data were modeled with a boxcar design convolved with the hemodynamic response function. Global normalization, temporal smoothing, detrending, and high-pass filtering were performed as part of the SPM analysis.
Random effects analyses were used to generate an activation map for each condition using one-sample t tests. Paired t tests were used to assess for differences between conditions, and two-sample t tests were used to assess for between-group differences. In addition, correlation analyses were performed using the weekly caffeine intake from each subject. The SPMs were thresholded at a P Ͻ 0.001 and corrected for multiple comparisons using a spatial extent (P Ͻ 0.05) threshold based on the theory of Gaussian fields (Worsley et al., 1996) . Statistical analyses were performed using small volume corrections based on the hypotheses that activation differences would be observed in sensoryspecific cortices. All analyses were limited to temporal and occipital lobes. Whole-brain analyses were not performed as part of this study. The masked regions were defined in an automated fashion using the Talairach Daemon (http://ric. uthscsa.edu/projects/ talairachdaemon.html). MNI coordinates were first converted into the Talairach coordinate system (Talairach and Tournoux, 1988) using a nonlinear transform (Duncan et al., 2000) , and anatomic and Brodmann areas (BAs) were then determined using the Talairach Daemon (Lancaster et al., 2000) .
The total response magnitude was calculated by multiplying the mean percentage of signal change in each significantly activated cluster by the cluster volume for each subject. Response magnitudes were analyzed using two-way analysis of variance (ANOVA) with repeated measures on the treatment factor (caffeine vs placebo). This design tested for within-subject differences between caffeine and placebo, between-subjects differences related to level of dietary caffeine use, and interaction effects between dietary caffeine use and caffeine-induced changes in the BOLD response.
RESULTS
As expected, this passive visual stimulation resulted in activation of visual cortex in high and low caffeine users under placebo and caffeine conditions (Fig. 1) . The regions of activation for both groups under both conditions included BAs 17-19. It is clear that the high users on caffeine produced the greatest BOLD signal change, while the low users on caffeine produced the least signal change. Talairach coordinates for the peak response for the high users on caffeine was located at x ϭ 4, y ϭ Ϫ69, and z ϭ 13 (t ϭ 19.4, P Յ 0.05 corrected). The peak response for the low users on caffeine was located at x ϭ Ϫ24, y ϭ Ϫ93, and z ϭ 1 and had a much lower t score (t ϭ 10.41, P Յ 0.05 corrected). The peak response for high users on placebo remained in primary visual cortex (x ϭ Ϫ16, y ϭ Ϫ85, and z ϭ 14), but the t score was much lower than that observed under the caffeine condition (t ϭ 11.74, P Յ 0.05 corrected). The peak response for low users on placebo was also located in primary visual cortex as observed for the caffeine condition (x ϭ 4, y ϭ Ϫ44, and z ϭ Ϫ50). Interestingly, however, the t score was higher under the placebo condition (t ϭ 12.91, P Յ 0.05 corrected), and the area of activation was larger.
Comparisons of the signal change between the two study populations on caffeine revealed that high users generated significantly more BOLD signal change than low users during visual stimulation (Fig. 2) . The peak difference was located at x ϭ Ϫ12, y ϭ Ϫ89, and z ϭ 14 (t ϭ 6.1, P Յ 0.05 corrected), and the cluster spanned the cuneus gyrus, including BAs 17 and 18. This cluster was located predominately in the left hemisphere, but a small portion was present on the right. The total magnitude of activation was calculated for each population for each condition (Fig. 3) . This metric also revealed that under the caffeine condition, high users responded to visual stimulation with a greater signal change than did low users as determined by ANOVA (F(1,18) ϭ 4.571, P ϭ 0.047).
Since prior caffeine consumption results in an upregulation of adenosine receptors and there was a range of caffeine use among the study participants, a correlation analysis was performed to determine if regional BOLD signal changes were dependent on dietary caffeine use regardless of study group assignment. This analysis revealed that the visual stimulusinduced BOLD signal change while on caffeine was significantly correlated with prior use (Fig. 4) . A portion of the cuneus gyrus exhibited BOLD changes that correlated with caffeine intake (x ϭ Ϫ16, y ϭ Ϫ89, and z ϭ 18; t ϭ 6.0, P Յ 0.05 corrected), spanned BAs 18 and 19, and overlapped the area that showed significantly greater BOLD signal in high users. In addition, portions of the bilateral fusiform and lingual gyri (BAs 18 and 19) were correlated with caffeine intake.
Statistical comparisons of the caffeine and placebo conditions in each study population demonstrated trends for caffeine to increase the BOLD signal in high users and decrease the signal in low users, and while visually obvious differences are present (Fig. 1) , these differences did not survive correction for multiple comparisons. Analyses of the auditory stimulation data (Fig. 5) revealed similar trends to those observed in the visual stimulation experiment. Activation in high users was greatest while on caffeine, whereas activation in low users was greatest while on placebo. Although the between-and within-group differences did not reach statistical significance, the data demonstrate a trend for caffeine-induced increases in the auditory BOLD signal in high users and decreases in low users.
DISCUSSION
The effects of caffeine on BOLD fMRI measures is of considerable interest because caffeine modulates both neural activity and neurovascular tone. The data presented here demonstrate that the effects of caffeine on fMRI BOLD measurements following a 30-h withdrawal period are different in high and low caffeine users. In the presence of caffeine, high users generated a greater BOLD signal change than low users. However, the categorization of high and low caffeine user groups was necessarily somewhat arbitrary. To remove this categorization confound, a correlation analysis was performed which demonstrated a positive relationship between caffeine use and BOLD signal change and supports these findings, independent of subject grouping. The differential effects observed in these two populations are likely due to the summed effects of caffeine on two of the adenosine receptors (A 1 and A 2A ) found in the central nervous system.
Caffeine has an excitatory action on neurons through blockade of A 1 adenosine receptors (Dunwiddie and Masino, 2001; Haas and Selbach, 2000; Ralevic and Burnstock, 1998) . Caffeine also blocks A 2A and A 2B adenosine receptors on cerebral vasculature, resulting in vasoconstriction (Dunwiddie and Masino, 2001; Feoktistov and Biaggioni, 1997; Moreau and Huber, 1999; Ngai et al., 2001; Shin et al., 2000) . Both of these actions by caffeine have the potential to modify fMRI results, as the BOLD signal is a function of both neural activity and changes in vascular tone (through cou- 
FIG. 2.
Group difference maps for visual stimulation. SPMs show the area of visual cortex where the BOLD signal change was significantly greater in high users than low users under the caffeine condition. The two axial slices are located at z ϭ 13 and z ϭ 17 (from left to right), and the t score calibration bar applies to both images.
FIG. 3.
Response magnitude plots for visual stimulation. The magnitude of activation was calculated for each subject by multiplying the mean percentage of signal change by the number of voxels. The average total response magnitudes for each group and each condition are plotted with standard error for the group. The magnitude of response for the high users on caffeine was significantly greater than that of the low users on caffeine.
pling of neural activity to the hemodynamic response (Logothetis et al., 2001; Raichle, 1998) ).
Since caffeine is a nonselective antagonist of both A 2 and A 1 receptors, the effect of caffeine on the BOLD signal should be some combination of the enhanced neural activity that would occur by blocking A 1 receptors and the decreased vascular responsiveness due to blockade of A 2A and A 2B receptors. The net effect of caffeine on the BOLD signal would depend on which of the two receptor systems' effects is dominant. In low users, the number of adenosine receptors presumably closely represents a "normal" steady state, and the ratio of A 1 :A 2 receptor effects on the BOLD signal favors vascular reactivity over changes in neural activity. During regional neural activity adenosine binds to vascular receptors and results in vasodilatation and the observed BOLD signal increase. At the same time, the adenosine acts on neural receptors to prevent excess neural activity and protect neurons from excitotoxicity (Ralevic and Burnstock, 1998) . This inhibitory (Fig. 2) . The two axial slices are located at z ϭ Ϫ12 and z ϭ 17 (from top to bottom), and the t score calibration bar applies to both images. The correlation plot shows each subject's response amplitude (in arbitrary MR units) plotted against the weekly caffeine consumption. The data for this graph were taken from the peak voxel in the correlation maps (x ϭ Ϫ16, y ϭ Ϫ89, z ϭ 18). The linear regression line was fit to all subjects' data (R 2 ϭ 0.63). FIG. 5. Statistical parametric maps for auditory stimulation. SPMs show areas of significant BOLD signal change during auditory stimulation for high (top) and low (bottom) caffeine users. SPMs from each subject population are shown for both caffeine (left) and placebo (right) challenges. The same three sections through auditory cortex located at Talairach planes z ϭ Ϫ2, 6, and 13 (from left to right) are shown for each condition. The t score calibration bar applies to all images. neural response must not exceed the regional excitatory neural activity under normal conditions or all neural activity would be inhibited. Thus, in the presence of caffeine (adenosine antagonist), it is expected that low users will experience more vasoconstriction (A 2 antagonism) than neural excitation (A 1 antagonism), resulting in a diminished BOLD signal.
The response of high users to a caffeine challenge is likely to be quite different due to the fact that chronic caffeine use increases the number of neural A 1 adenosine receptors while total brain A 2A receptor numbers either remain unchanged or are just slightly increased (Johansson et al., 1993; Ralevic and Burnstock, 1998; Shi and Daly, 1999) . Thus, the caffeine-induced increases in neural activity associated with A 1 receptor upregulation will dominate any vasoconstriction that occurs due to A 2 receptor antagonism. We propose that this differential weighting of the A 1 and A 2 effects of caffeine in the two study populations is responsible for the increase in BOLD signal observed in high users compared to low users.
Although group differences in the BOLD signal in visual cortex observed in this study were statistically significant, the results in auditory cortex demonstrated similar trends but did not reach significance. There are several possible reasons for this observation. First, the within-group variance of the BOLD signal changes in auditory cortex was greater than that in visual cortex. Second, the magnitude of the BOLD signal changes was much greater in visual cortex than in auditory cortex, likely due to differences in the background activity and the relative effectiveness of each sensory stimulus. Finally, visual and auditory cortices reside in different vascular territories and are, therefore, supplied by different vessels. It has recently been demonstrated that the resting cerebral perfusion in these two regions may be differentially affected by caffeine . Such differences may reflect differences in adenosine receptor numbers or affinity and could account for the differences in BOLD signal change observed in visual and auditory cortices.
In conclusion, we demonstrated that the BOLD signal change was significantly greater in high caffeine users than in low users when given a caffeine dose equivalent to about two cups of coffee. These results suggest that prior to an fMRI study subjects should go about their usual daily routine, with users consuming their normal caffeine and nonusers abstaining from use. Recent work has suggested that caffeine may act universally as a BOLD signal enhancer (Mulderink et al., 2002; Parrish et al., 2001 ), but as these authors suggest, and we demonstrate here, the effect of caffeine on the BOLD signal is dependent on the baseline caffeine intake to which the individual is accustomed.
